REGN vs AMGN: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Amgen Inc in 2026
REGN
Regeneron Pharmaceuticals Inc
$781.67
AMGN
Amgen Inc
$388.16
Key Metrics Comparison
| Metric | REGN | AMGN | Winner |
|---|---|---|---|
| Market Cap | $82.64B | $209.24B | AMGN |
| P/E Ratio | 18.83 | 27.24 | REGN |
| EPS (TTM) | $41.51 | $14.25 | REGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 44.6% | 70.8% | AMGN |
Analyze REGN
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or AMGN a better investment?
Comparing REGN and AMGN: Regeneron Pharmaceuticals Inc has a market cap of $82.64B while Amgen Inc has $209.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and AMGN?
REGN (Regeneron Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or AMGN?
Based on P/E ratios, REGN trades at a lower multiple (18.8x vs 27.2x).
Which is growing faster: REGN or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for REGN.
Which company is more profitable: REGN or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 44.6% for REGN.
Which is the larger company: REGN or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $209.24B compared to $82.64B for REGN.
Should I buy REGN or AMGN in 2026?
Both REGN and AMGN have investment merit. REGN trades at $781.67 while AMGN trades at $388.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and AMGN stock?
Key differences: Market Cap ($82.64B vs $209.24B), P/E Ratio (18.8x vs 27.2x), Revenue Growth (0.0% vs 0.1%), Gross Margin (44.6% vs 70.8%).